Hepatic Resection Versus Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: A Cohort Study

por Lu, Linbin, Zheng, Peichan, Wu, Zhixian, Chen, Xiong
Publicado 2021

Elevated Platelet Count is Associated with Poor Survival After Transarterial Chemoembolization Treatment in Patients with Hepatocellular Carcinoma: A Cohort Study

por Lu, linbin, Zhang, Yan, Zheng, Peichan, Wu, Zhixian, Wang, Xuewen, Chen, Yaying, Chen, Xiong
Publicado 2020

Association between platelet count and hepatocellular carcinoma overall survival: a large retrospective cohort study

por Lu, Linbin, Su, Zhimin, Zheng, Peichan, Wu, Zhixian, Zhang, Yan, He, Huimin, Liu, Jingnan, Lin, Shan, Chen, Xiong
Publicado 2020

The aMAP Score is an Independent Risk Factor for Intermediate-stage Hepatocellular Carcinoma: A Large Retrospective Cohort Study

por Chen, Yaying, Shi, Yanhong, Lu, Linbin, Wang, Xuewen, Lin, Qin, Lin, Yihong, Wang, Ruiqi, Zhu, Hongwu, Zheng, Peichan, Chen, Xiong
Publicado 2023

Capn4 is induced by and required for Epstein‐Barr virus latent membrane protein 1 promotion of nasopharyngeal carcinoma metastasis through ERK/AP‐1 signaling

por Zheng, Peichan, Chen, Xiong, Xie, Jianqin, Chen, Xi, Lin, Shanshan, Ye, Lixiang, Chen, Lingfan, Lin, Jing, Yu, Xiangbin, Zheng, Ming
Publicado 2019